Clopidogrel 75mg 30 tablets

Composition:
active ingredient: clopidogrel; 1 tablet contains clopidogrel bisulfate 97.86 mg, equivalent to 75 mg clopidogrel excipients: lactose, microcrystalline cellulose, crospovidone, glycerol dibehenate, talc shell: Opadry II 85G34669 pink (polyvinyl alcohol, talc, macrogol 3350, lecithin, titanium dioxide (E 171), iron oxide red (E172)).

Pharmacotherapeutic group:
Platelet aggregation inhibitors other than heparin. ATX code B01A C04.

Indications:
Secondary prevention of manifestations of atherothrombosis in adults In patients who have had a myocardial infarction (beginning of treatment – after a few days, but no later than 35 days after the onset), ischemic stroke (beginning of treatment – after 7 days, but no later than 6 months after the onset) or who are diagnosed with diseases peripheral arteries (damage to the arteries and atherothrombosis of the vessels of the lower extremities)

In patients with acute coronary syndrome: without ST segment elevation (unstable angina or non-Q wave myocardial infarction), including in patients who received a stent during percutaneous coronary angioplasty, in combination with acetylsalicylic acid (ASA) with acute ST-segment elevation myocardial infarction, in combination with acetylsalicylic acid (in patients who receive standard medical treatment and who are indicated for thrombolytic therapy).